Managing the introduction of new and high-cost drugs in challenging times: the experience of Hungary and Poland

Kwong, Danica, Ferrario, Alessandra, Adamski, Jajub, Inotai, Andras and Kalo, Zoltan (2014) Managing the introduction of new and high-cost drugs in challenging times: the experience of Hungary and Poland. Eurohealth, 20 (2). pp. 25-28. ISSN 1356-1030

Preview

PDF - Published Version Download (301kB) | Preview

• Publisher

Abstract

Hungary and Poland are currently facing budgetary pressures to reduce health and pharmaceutical spending. However, they still must ensure that valuable innovative medicines are made available to patients. Risk-sharing schemes (RSSs) are a mechanism to achieve access, particularly for high-cost innovative medicines that payers might be reluctant to fund because of uncertainty around their cost-effectiveness in real life. RSSs can be designed to distribute financial risks, risks relating to health outcomes or a combination of both. Due to fiscal imperatives and complexities linked to the implementation of health outcome-based schemes, both countries have focused mainly on financial RSSs.

Item Type:	Article
Official URL:	http://www.euro.who.int/
Additional Information:	© 2014 WHO on behalf of European Observatory on Health Systems and Policies
Divisions:	Social Policy LSE Health
Subjects:	H Social Sciences > HN Social history and conditions. Social problems. Social reform R Medicine > RM Therapeutics. Pharmacology
Date Deposited:	08 Jul 2014 16:13
Last Modified:	14 Sep 2024 06:34
URI:	http://eprints.lse.ac.uk/id/eprint/57588

Actions (login required)

View Item